Bourse

ACTICOR BIOTECH provided an update on its clinical developments evaluating glenzocimab in the treatment of myocardial infarction. LIBERATE: A phase 2b study evaluating glenzocimab in the treatment of myocardial infarction. The Phase 2b, randomized, double-blind LIBERATE study will include more than 212 patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). The … Read more

On the rise Imerys (+3%): The French mineral specialties giant benefits from the optimism of Berenberg, which maintains its buy recommendation and increases its price target from 45 to 47 euros. The German bank predicts an improvement in margins and favorable pricing dynamics from the fourth quarter, highlighting continued volume growth, particularly in the United … Read more

The number of MPOX virus infections in Uganda has risen to ten and all patients are suffering from a strain of the virus, clade 1b, which is more easily transmitted from person to person, a health official said on Saturday. The country borders the Democratic Republic of Congo, where the current outbreak began in January … Read more

Bavarian Nordic A/S announced that the company has obtained prequalification from the World Health Organization (WHO) for IMVANEX® (MVA-BN®), the first smallpox vaccine to be added to the WHO prequalification list. MVA-BN is indicated for active immunization against smallpox, variola and orthopoxvirus infections and diseases in all adults aged 18 years and older. However, according … Read more